Quality of life concerns; living with MDS
Rena Buckstein, MD, FRCPC, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, Canada, discusses the quality of life (QoL) of patients with myelodysplastic syndromes, and the factors contributing to reductions and improvements in QoL. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.
Related videos
